Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Cyclophosphamide vs Doxorubicin in Elderly STS
NCT04757337Phase 3Recruiting
- Sponsor
- Unicancer
- Start
- Jun 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide in soft tissue sarcoma (STS), sponsored by Unicancer. Started Jun 2021; status: recruiting.
02
Drugs
cyclophosphamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04757337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04757337.